Keywords: b-ms/az, drug, shows, improvements, across, all, glycemic

B-MS/AZ drug shows improvements across all glycemic measures

Article | 08 June 2009

Results from a 12-week, Phase III study presented at the meeting of the American Diabetes Association suggest that the sodium ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in